Congratulations Luca Arecco, MD 👏🏻

Congrats! Another milestone from this international collaboration 👏🏻👏🏻 Eva Blondeaux

Proud of my great Università di Genova colleague and friend Marta Perachino presenting in oral session 1 at #ESMOBreast25 new results from the 🌍 BRCA-BCY study led by Matteo Lambertini, MD PhD! In young BRCA carriers, pregnancy after breast cancer during pregnancy is feasible and safe ✅ OncoAlert

Safety of pregnancy after the diagnosis of breast cancer during pregnancy Marta Perachino Matteo Lambertini, MD PhD Elisa Agostinetto #ESMOAmbassadors #ESMOBreast25 ESMO - Eur. Oncology

We should become familiar with using AMH levels for evaluating the risk of developing gonadotox from oncologic treatments 💉 ❌but not consider it a biomarker of likelihood of future pregnancies 🤰🏼 ESMO - Eur. Oncology Matteo Lambertini, MD PhD #ESMOBreast25

Great talk of Matteo Lambertini, MD PhD on #ESMOBreast25 supportive care key takeaways👏🏻waiting for tomorrow for very important #BCY session!@OncoAlert

Once Università di Genova always #UniGenova ❤️

#INSIEME AIOM OncoAlert Ospedale San Martino Genova Università di Genova Francesca Poggio Marco Tagliamento Davide Soldato Carlo Genova Luca Arecco, MD Alessandra Gennari MD PhD Benedetta Conte Simone Nardin Marta Perachino Maria Grazia Razeti ChiaraMolinelli Diletta Favero

Following Marta Perachino presentation at #ESMOBreast25, published in ESMO Open results from the #BRCABCY collaboration, demonstrating the feasibility and safety of having a #pregnancy after a previous pregnancy-associated BC diagnosis. Thanks to Matteo Lambertini, MD PhD for leading this

This Journal of Clinical Oncology piece is one of the most poignant text I have ever read. A must-read for all oncologists OncoAlert ascopubs.org/doi/10.1200/JC…

NEWS FROM INDUSTRY: monarchE Update Source Lilly buff.ly/9ebwj2M Eli Lilly announced that the Phase 3 monarchE trial has met its primary overall survival (OS) endpoint, showing that two years of abemaciclib plus endocrine therapy (ET) provides a statistically

👏 140 personas han participado en la XV Edición del #PaseícoDeLaMama. El equipo de mama ha explicado a qué proyecto se destinarán los fondos recaudados y ha agradecido 15 años de apoyo y generosidad en favor de la investigación en cáncer de mama en VHIO 🩷 #MamaVHIO

Dear Colleagues at #ESMO25 An honor to introduce our OncoAlert 🚨Faculty Lucia Del Mastro 🇮🇹 discussing the results of #monarchE 🦋 in #BreastCancer Presentati a #ESMO25 i risultati aggiornati dello studio monarchE che dimostrano come abemaciclib nel trattamento adiuvante

#INSIEME a Lucia Del Mastro per AIOM 🎯🎯

👏 Enhorabuena Marta Perachino ‼️ La investigadora del Grupo #MamaVHIO recibe la primera beca del Gilead Sciences Research Scholars Program otorgada en España.  El proyecto INSP3KTION busca entender mejor cómo se desarrolla el #CáncerDeMama ➡️ linke.to/INSP3KTIONGile…

Thank you Gilead Sciences for helping us moving forward with our research and Vall d’Hebron Institute of Oncology (VHIO) for the trust and support💫 And now it’s time to get started 💪🏻💪🏻